Physician profile
Kyle Hardacker
NPI 1316505795
$7,714.24
in general payments reported to CMS, 2019-2025
10 companies · $3,796 in 2025
The $3,796 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.10 · 2020: $16.14 · 2021: $261 · 2022: $219 · 2023: $2,312 · 2024: $1,097 · 2025: $3,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,078 · Travel and Lodging: $3,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,078.39 |
| Travel and Lodging | $3,127.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,042.53 | 2022-2025 | Affixus, Znn, Ncb |
| Medical Device Business Services, INC. | $2,272.01 | 2025 | Conduit |
| Stryker Corporation | $759.88 | 2019-2025 | T2 Alpha, Gamma, Variax |
| Medtronic, INC. | $754.19 | 2025 | Mazor X System, Graftonand Grafton Plusdemineralized Bone Matrix (Dbm), Stealthstation S8 Platform |
| Cerapedics INC. | $230.61 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Acuity Surgical Devices, LLC | $204.69 | 2025 | |
| Davol INC. | $162.80 | 2024 | |
| Globus Medical, INC. | $148.10 | 2021 | |
| Nuvasive, INC. | $79.01 | 2021 | |
| Blue Surgical LLC | $60.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Hardacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.